News | February 02, 2009

MRI Used to Demystify Cardiovascular Consequences of Obstructive Sleep Apnea

February 2, 2009 - Researchers at the Ohio State University Medical Center are using cardiac magnetic resonance imaging to assess the effects of a common treatment for sleep apnea on heart structure and function in otherwise healthy individuals.
The study authored by Ulysses Magalang, M.D. and Subha Raman, M.D. appears in the Journal of Clinical Sleep Medicine.
“Little data exists on continuous positive airway pressure’s therapeutic effects on the heart’s right side, so we are leveraging the advantages of imaging to see if the treatment helps these patients,” said Dr. Magalang, medical director of Ohio State’s Sleep Disorders Center.
Researchers found that continuous positive airway pressure therapy (CPAP) improves heart structure with improvements in the volume of the right ventricle. CPAP is administered by a device that delivers continuous positive airway pressure during sleep. The device encompasses a mask worn over the nose, tubing and a fan that delivers enough air pressure to keep the throat open, preventing obstruction of the airway, and reversing the negative consequences of sleep apnea on the heart.
“By getting clear pictures of the heart in these patients, we were able to better understand the cardiovascular consequences of obstructive sleep apnea. These results can be used to guide treatments to reduce death and disability due to heart disease,” said Dr. Raman, medical director of the cardiac magnetic resonance and computerized tomography program at Ohio State’s Richard M. Ross Heart Hospital.
Drs. Magalang and Raman recently collaborated on a study published in the journal Experimental and Clinical Endocrinology & Diabetes showing a possible link between sleep apnea and heart disease, which is the leading cause of death responsible for 29 percent of people worldwide. The researchers identified a substance that may prevent atherosclerosis.
For more information: www.osumc.edu

Related Content

Russian Team Developing New Technology to Significantly Reduce MRI Research Costs
News | Magnetic Resonance Imaging (MRI)| January 16, 2018
January 16, 2018 — Researchers from the NUST MISIS Engineering Center for Industrial Technologies in Russia have deve
Videos | Magnetic Resonance Imaging (MRI)| December 13, 2017
Emanuel Kanal, M.D., director of MRI services and professor of radiology and neuroradiology at the University of Pitt
GE Healthcare Launches Blanket-Like Air Technology MRI Coils
Technology | Magnetic Resonance Imaging (MRI)| December 13, 2017
GE Healthcare announced U.S. FDA 510(k) clearance of its new Air Technology, what it calls an industry-first suite of...
Toshiba Vantage Galan 3T XGO Edition MRI Features New Advanced Gradient
Technology | Magnetic Resonance Imaging (MRI)| December 11, 2017
Toshiba Medical, a Canon Group company, demonstrated the Vantage Galan 3T XGO Edition with the all-new Saturn X...
Toshiba Launches Vantage Elan Zen Edition MR for Enhanced Patient Comfort
Technology | Magnetic Resonance Imaging (MRI)| December 05, 2017
Toshiba Medical, a Canon Group company, introduced its newest magnetic resonance (MR) system, the Vantage Elan/Zen...
FDA Clears Siemens Magnetom Terra 7T MRI Device

The FDA has cleared the Siemens Magnetom Terra as the first 7T MRI system in the U.S. to gain regulatory approval.

Technology | Magnetic Resonance Imaging (MRI)| October 12, 2017
The U.S. Food and Drug Administration (FDA) cleared the first 7 Tesla (7T) magnetic resonance imaging (MRI) device,...
MR Solutions Showcases Multimodality MRI Solutions on Two Continents
News | Magnetic Resonance Imaging (MRI)| October 11, 2017
MR Solutions took their cryogen-free preclinical multimodality magnetic resonance imaging (MRI) solutions on tour in...
Toshiba Showcases MRI Workflow Enhancements at RSNA 2017
News | Magnetic Resonance Imaging (MRI)| September 21, 2017
September 21, 2017 — Toshiba Medical will highlight its latest...
GE Healthcxare Signa Pioneer MAGIC six contrasts in one scan software by SyntheticMR.

The MRI software enables several different contrasts to be obtained from one scan, shortening scan times.

Feature | Magnetic Resonance Imaging (MRI)| August 31, 2017
August 31, 2017 — The U.S. Food and Drug Administration (FDA) has granted market clearance for SyntheticMR’s SyMRI.
ISMRM Issues Guidelines for MRI Gadolinium Contrast Agents
News | Magnetic Resonance Imaging (MRI)| August 15, 2017
The International Society for Magnetic Resonance in Medicine (ISMRM) has provided new guidance in the use of contrast...
Overlay Init